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We appreciate the thoughtful com-
ments that Cantinotti and colleagues
expressed in their letter. Cantinotti
and colleagues are to be commended
for their important body ofwork,which
has advanced the understanding of
B-type natriuretic peptide (BNP) levels
in pediatric patients with congenital
heart disease.1
We agree that levels of BNP are age
dependent both in healthy neonates and
in those with congenital heart disease.
Also, as we indicated in the recent
article under discussion,2 the rapid
changes in BNP levels after surgical in-
tervention (within hours of the opera-
tion) imply that there are physiologic
changes associated with the specific
surgical interventions because of the
particular underlying cardiac defects
that determine the release of BNP.
Indeed, neonates with univentricular
physiology havevery highpreoperative
BNP levels relative to those of age-
matched healthy neonates and also rel-
ative to those with left-to-right shunts.
In our study, there was also a trend to-
ward higher BNP levels in neonates
with univentricular physiology relative
to those undergoing an arterial switch
operation.We believe this is one reason
that studies grouping neonates into sin-
gle cohorts,3,4 without consideration1416 The Journal of Thoracic andfor the specific cardiac defects, have
not found the postoperative decreases
in BNP that both we2 and Cantinotti
and colleagues1 found.
We therefore caution against relying
on disease severity scoring systems that
group diverse cardiac defects within
particular categories or combine vari-
ous diagnostic criteria, such as the
Risk Adjustment for Congenital Heart
Surgery 1 and Aristotle Basic Com-
plexity scores, for the interpretation of
perioperative BNP levels. Indeed, these
scoring systemsdonot fully account for
the variability in outcomes seen, dem-
onstrating that other factors remain
important.5 In attempting to understand
better the physiologic release of a bio-
marker and its implications for prog-
nostication and goal-directed therapy,
the use of such scoring systems is there-
fore likely to fall short in accounting for
the variability in levels of the bio-
marker. In fact, in Figure 1 of the letter
of Cantinotti and colleagues, neonates
in Aristotle Basic Complexity cate-
gories II and III can be seen to have
more variability in BNP levels than
those in category IV, probably because
of the differences in cardiac lesions and
the physiologic changes associated
with surgery that inherently differ by
category in these systems.A further ex-
ample of the specificitywe described in
our study was shown in preliminary
data from our previous work, where
we found that preoperative BNP level
in patients undergoing a total cavopul-
monary connection (Fontan procedure)
was the only significant predictor of
adverse postoperative outcomes.6
There is clearly much to learn about
the mechanisms involved in BNP re-
lease in patients with congenital heart
disease and the utility of this biomarker
in this population. We agree with Can-
tinotti and colleagues that further inves-
tigations into BNP changes during the
perioperative period are warranted.
On the basis of our combined data to
date, we believe that fully understand-
ing and interpreting perioperative
BNP changes will require accounting
for age, the cardiac lesion, and theCardiovascular Surgery c May 2013intervention that is undertaken. We
thank both the Editor and Cantinotti
and colleagues for this opportunity to
highlight this important topic.
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MYTH OR FACT?
To the Editor:
We read with great interest the arti-
cle entitled, ‘‘Tracheal regeneration:
Evidence of bone marrow mesenchy-
mal stem cell involvement,’’ by
Seguin and coworkers.1 We congratu-
late Seguin and coworkers1 for their
convincingdemonstration ofbonemar-
row–derived stem cell migration to the
grafted area after tracheal replacement
